Matches in Nanopublications for { ?s ?p "[Core binding factor (CBF) leukemias, those with translocations or inversions that affect transcription factor genes RUNX1 or CBFB, account for ~24% of adult acute myeloid leukemia (AML) and 25% of pediatric acute lymphocytic leukemia (ALL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- NP377151.RAheDhDzCwlTo-Tao1Z8MFBwObao5vMJ9_btbl3xPHGoA130_assertion description "[Core binding factor (CBF) leukemias, those with translocations or inversions that affect transcription factor genes RUNX1 or CBFB, account for ~24% of adult acute myeloid leukemia (AML) and 25% of pediatric acute lymphocytic leukemia (ALL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP377151.RAheDhDzCwlTo-Tao1Z8MFBwObao5vMJ9_btbl3xPHGoA130_provenance.
- NP491036.RA_cPWj74qi_HmUg2wjEQzwxKblvH6g3myY3Fa0dQnNwg130_assertion description "[Core binding factor (CBF) leukemias, those with translocations or inversions that affect transcription factor genes RUNX1 or CBFB, account for ~24% of adult acute myeloid leukemia (AML) and 25% of pediatric acute lymphocytic leukemia (ALL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP491036.RA_cPWj74qi_HmUg2wjEQzwxKblvH6g3myY3Fa0dQnNwg130_provenance.
- NP285189.RA4h97QXsr1bmFvMeTjKAdl5s_eOFqPzpRc2XXHJ0QBKc130_assertion description "[Core binding factor (CBF) leukemias, those with translocations or inversions that affect transcription factor genes RUNX1 or CBFB, account for ~24% of adult acute myeloid leukemia (AML) and 25% of pediatric acute lymphocytic leukemia (ALL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP285189.RA4h97QXsr1bmFvMeTjKAdl5s_eOFqPzpRc2XXHJ0QBKc130_provenance.
- NP286206.RA5eyvauOA0-vrpFPlfkaIpDf4ucReSbfPFGQTTbPWm_c130_assertion description "[Core binding factor (CBF) leukemias, those with translocations or inversions that affect transcription factor genes RUNX1 or CBFB, account for ~24% of adult acute myeloid leukemia (AML) and 25% of pediatric acute lymphocytic leukemia (ALL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP286206.RA5eyvauOA0-vrpFPlfkaIpDf4ucReSbfPFGQTTbPWm_c130_provenance.
- assertion description "[Core binding factor (CBF) leukemias, those with translocations or inversions that affect transcription factor genes RUNX1 or CBFB, account for ~24% of adult acute myeloid leukemia (AML) and 25% of pediatric acute lymphocytic leukemia (ALL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Core binding factor (CBF) leukemias, those with translocations or inversions that affect transcription factor genes RUNX1 or CBFB, account for ~24% of adult acute myeloid leukemia (AML) and 25% of pediatric acute lymphocytic leukemia (ALL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Core binding factor (CBF) leukemias, those with translocations or inversions that affect transcription factor genes RUNX1 or CBFB, account for ~24% of adult acute myeloid leukemia (AML) and 25% of pediatric acute lymphocytic leukemia (ALL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Core binding factor (CBF) leukemias, those with translocations or inversions that affect transcription factor genes RUNX1 or CBFB, account for ~24% of adult acute myeloid leukemia (AML) and 25% of pediatric acute lymphocytic leukemia (ALL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP285004.RANSz8mX8Ur7IYfu_-0GsfyD6pkzLXispPVmNr8NTfAGc130_assertion description "[Core binding factor (CBF) leukemias, those with translocations or inversions that affect transcription factor genes RUNX1 or CBFB, account for ~24% of adult acute myeloid leukemia (AML) and 25% of pediatric acute lymphocytic leukemia (ALL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP285004.RANSz8mX8Ur7IYfu_-0GsfyD6pkzLXispPVmNr8NTfAGc130_provenance.
- NP1007147.RAEiLRrcLbj32g3K28TN626mRM0Q1LSqsHGKnS9EPl6dE130_assertion description "[Core binding factor (CBF) leukemias, those with translocations or inversions that affect transcription factor genes RUNX1 or CBFB, account for ~24% of adult acute myeloid leukemia (AML) and 25% of pediatric acute lymphocytic leukemia (ALL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1007147.RAEiLRrcLbj32g3K28TN626mRM0Q1LSqsHGKnS9EPl6dE130_provenance.
- NP1007149.RAMBVN2lS1LJ3Vo36q28Hksk7rggNOleky6jjdxjBH5dQ130_assertion description "[Core binding factor (CBF) leukemias, those with translocations or inversions that affect transcription factor genes RUNX1 or CBFB, account for ~24% of adult acute myeloid leukemia (AML) and 25% of pediatric acute lymphocytic leukemia (ALL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1007149.RAMBVN2lS1LJ3Vo36q28Hksk7rggNOleky6jjdxjBH5dQ130_provenance.
- NP1007152.RAMwwRtdtXmjAAQf28hMmUyuqB5xnPKrDBfLa-nBDR7AI130_assertion description "[Core binding factor (CBF) leukemias, those with translocations or inversions that affect transcription factor genes RUNX1 or CBFB, account for ~24% of adult acute myeloid leukemia (AML) and 25% of pediatric acute lymphocytic leukemia (ALL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1007152.RAMwwRtdtXmjAAQf28hMmUyuqB5xnPKrDBfLa-nBDR7AI130_provenance.